Stocks and Investing
by (remove) : David Amsellem
RSSJSONXMLCSV
Stocks and Investing
by (remove) : David Amsellem
RSSJSONXMLCSV
Wed, September 11, 2024
Thu, August 8, 2024
Fri, August 2, 2024
Thu, June 27, 2024
Mon, May 13, 2024
Fri, May 10, 2024
Thu, April 11, 2024
Mon, April 1, 2024
Thu, March 28, 2024
Thu, March 21, 2024
Tue, March 5, 2024
Wed, February 28, 2024
Fri, February 16, 2024
Mon, February 12, 2024
Tue, January 16, 2024
Wed, January 3, 2024
Wed, November 22, 2023
Tue, November 14, 2023
Fri, November 10, 2023
Thu, November 9, 2023
Fri, October 27, 2023
Wed, October 25, 2023
Thu, August 10, 2023
Tue, August 8, 2023
Mon, August 7, 2023
Wed, June 7, 2023
Wed, May 10, 2023
Mon, May 8, 2023
Tue, March 7, 2023

David Amsellem Downgraded (SUPN) to Hold and Decreased Target to $36 on, Sep 11th, 2024


Published on 2024-10-28 14:11:43 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Downgraded "Supernus Pharmaceuticals, Inc." (SUPN) to Hold and Decreased Target from $41 to $36 on, Sep 11th, 2024.

David, nor any peers, have made any analyst calls on SUPN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources